Page last updated: 2024-09-05

erlotinib hydrochloride and lactic acid

erlotinib hydrochloride has been researched along with lactic acid in 3 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)
Trials
(erlotinib hydrochloride)
Recent Studies (post-2010)
(erlotinib hydrochloride)
Studies
(lactic acid)
Trials
(lactic acid)
Recent Studies (post-2010) (lactic acid)
4,3537863,03346,2633,34919,053

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Franklin, G; Kalaichelvan, VK; Manavalan, R; Marslin, G; Reddy, PN; Sheeba, CJ1
Dittmann, K; Fehrenbacher, B; Huber, S; Mayer, C; Paasch, A; Rodemann, HP; Schaller, M1
Li, S; Li, Z; Liu, S; Wang, Z; Zhao, F1

Other Studies

3 other study(ies) available for erlotinib hydrochloride and lactic acid

ArticleYear
Poly(D,L-lactic-co-glycolic acid) nanoencapsulation reduces Erlotinib-induced subacute toxicity in rat.
    Journal of biomedical nanotechnology, 2009, Volume: 5, Issue:5

    Topics: Animals; Dose-Response Relationship, Drug; Drug Compounding; Drug-Related Side Effects and Adverse Reactions; Erlotinib Hydrochloride; Lactic Acid; Materials Testing; Nanocapsules; Nanomedicine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quinazolines; Rats; Rats, Wistar

2009
Nuclear EGFR renders cells radio-resistant by binding mRNA species and triggering a metabolic switch to increase lactate production.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2015, Volume: 116, Issue:3

    Topics: Blotting, Western; Bronchial Neoplasms; Cell Line, Tumor; Cell Nucleus; Dasatinib; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; Nuclear Proteins; Oxadiazoles; Protein Kinase Inhibitors; Pyrazoles; Radiation Tolerance; RNA, Messenger

2015
Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Adenocarcinoma of Lung; Erlotinib Hydrochloride; Etoposide; Gefitinib; Humans; Immunologic Factors; Immunotherapy; Lactic Acid; Lung Neoplasms; Prognosis; Reproducibility of Results; Tumor Microenvironment

2022